Streetbeat News

Earnings

SNGX

Soligenix (NASDAQ:SNGX) reported Q4 earnings, beating estimates with an EPS of $-0.06 versus the expected $-0.19, a 68.0% beat. However, revenue was down $160 thousand from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 1.0% the following day.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 1:35 pm

HCTI

Healthcare Triangle (HCTI) reported its Q4 earnings with an EPS of $(1.26), an improvement from $(1.33) year-over-year. However, sales decreased to $7.10M from $11.30M in the same period.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 1:35 pm

HCTI

Healthcare Triangle (HCTI) reported a decrease in both GAAP EPS and revenue for Q4 2023 compared to the same period last year. GAAP EPS fell to $1.26 from $1.33, and revenue dropped 37% to $7.1 million.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 1:31 pm

EBIZ

GRPN

SOCL

Groupon Inc (NASDAQ:GRPN) reported Q4 fiscal 2023 revenue of $137.7 million, surpassing consensus estimates but declining 7% Y/Y. Adjusted EPS was $0.30, beating expectations. Despite initial gains, GRPN shares later dropped. North America and International revenues fell due to decreased demand in Goods categories, with global billings and units sold also declining. However, adjusted EBITDA improved significantly, and the company's liquidity position strengthened. Analysts predict a significant downside for GRPN shares, with an average 1-year price target of $7.5, indicating a 59.02% expected downside. GRPN's stock traded lower by 3.85% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 15, 2024 | 1:29 pm

LEN

Lennar Corporation (NYSE:LEN) reported Q4 earnings surpassing market expectations with earnings of $2.57 per share against estimates of $2.23. However, sales slightly missed expectations at $7.310 billion versus $7.388 billion expected. The company experienced a 28% increase in new orders and a 23% increase in deliveries year over year. Following the earnings announcement, analysts from Barclays, Wells Fargo, Evercore ISI Group, and UBS raised their price targets on Lennar. Despite the positive earnings report, Lennar shares fell 7.6% to close at $152.86.

Portfolio Pulse from Avi Kapoor

March 15, 2024 | 1:25 pm

AMPS

Altus Power's shares dropped following its announcement of disappointing Q4 financial results and a forecast for FY24 revenue that falls short of expectations.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 1:21 pm

RLX

RLX Technology Inc. (NYSE:RLX) shares rose in premarket trading after reporting Q4 adjusted earnings per ADS of $0.046, surpassing analyst expectations of $0.02, and revenue of $73.31 million, exceeding forecasts of $66.52 million. However, gross margin decreased to 23.7% from 43.6% due to a new excise tax and changes in revenue mix. The company also highlighted its strategic focus on integrating resources and optimizing its product portfolio in China.

Portfolio Pulse from Nabaparna Bhattacharya

March 15, 2024 | 1:14 pm

BLND

Blend Labs shares are trading higher following the announcement of their Q4 financial results, indicating a positive market response to the company's performance.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 1:11 pm

CDLX

GETY

MCHX

In Friday's pre-market session, several Communication Services stocks showed significant movement. Cardlytics and Getty Images Holdings reported Q4 earnings, leading to a 48.3% and 6.79% increase in their stock prices, respectively. Conversely, Marchex, Kuke Music Hldg, Gaxos.AI, Cheer Holding, Baosheng Media Gr, and Grom Social Enterprises saw declines following their earnings reports.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 1:06 pm

BTTX

LSDI

MDGL

SLS

In Friday's pre-market session, several healthcare stocks showed significant movement. Better Therapeutics (BTTX) led the gainers with an 85.4% increase, while SELLAS Life Sciences Gr (SLS) experienced the largest drop among the losers, decreasing by 33.5%. Other notable movers include Madrigal Pharmaceuticals (MDGL) with a 22.34% increase and Lucy Scientific Discovery (LSDI) with a 25.53% decrease. The movements were attributed to various factors including quarterly earnings reports.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 1:06 pm